Repligen Corp (NASDAQ:RGEN)

During the Trading Day
40.76 +0.02 / +0.05%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
40.76 0.00 / 0.00%
 
Volume: 14.3K
No recent news for Repligen Corp.

Today’s Trading

Previous close40.74
Today’s open40.47
Day’s range40.27 - 41.87
Volume386,073
Average volume (3 months)445,439
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio199.7
Price/Sales10.13
Price/Book11.95

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc-0.02-0.09%
MACKMerrimack Pharmaceut...-0.12-1.01%
ACORAcorda Therapeutics ...0.000.00%
NLNKNewLink Genetics Cor...+0.26+0.61%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers